Jason D. Brubaker - Concepedia

Concepedia

Author

Jason D. Brubaker

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

Brubaker, J.D., J. D. Brubaker, Jason Brubaker, Jason D. Brubaker

25

Publications

1.3K

Citations

14

H-Index

27

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)Blueprint Medicines (United States)Harvard University University of Connecticut

JD

About

Jason D. Brubaker is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, drug discovery, and organic chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	4	4	359
2	Medicine	4	4	136
3	Natural Sciences	3	3	370
4	Biochemistry	3	3	381
5	Health Sciences	1	1	16

Jason D. Brubaker

×

15

Publications

1.3K

Citations

13

H-Index

	Year	Citations
Precision Targeted Therapy with BLU-667 for <i>RET</i>-Driven Cancers Vivek Subbiah, Justin F. Gainor, Rami Rahal, Cancer Discovery	2018	386
A Convergent Enantioselective Route to Structurally Diverse 6-Deoxytetracycline Antibiotics Mark G. Charest, C. Lerner, Jason D. Brubaker, Science Enantioselective SynthesisBioorganic ChemistryEngineeringBiochemistryIsolated Natural Products	2005	294
Discovery of BLU-945, a Reversible, Potent, and Wild-Type-Sparing Next-Generation EGFR Mutant Inhibitor for Treatment-Resistant Non-Small-Cell Lung Cancer Meredith S. Eno, Jason D. Brubaker, John E. Campbell, Journal of Medicinal Chemistry	2022	146
A Robust Platform for the Synthesis of New Tetracycline Antibiotics Cuixiang Sun, Qiu Wang, Jason D. Brubaker, Journal of the American Chemical Society	2008	128
A Practical, Enantioselective Synthetic Route to a Key Precursor to the Tetracycline Antibiotics Jason D. Brubaker, Andrew G. Myers Organic Letters	2007	77
Reactions of Oxetan-3-<i>tert</i>-butylsulfinimine for the Preparation of Substituted 3-Aminooxetanes Philip J. Hamzik, Jason D. Brubaker Organic Letters Medicinal ChemistryBioorganic ChemistryBiochemistryNatural SciencesMedicine	2010	63
Identification of N-(1H-pyrazol-4-yl)carboxamide inhibitors of interleukin-1 receptor associated kinase 4: Bicyclic core modifications Jongwon Lim, Michael D. Altman, James Α. Baker, Bioorganic & Medicinal Chemistry Letters InflammationMedicinal ChemistryDrug TargetKinase 4Anti-inflammatory	2015	32
Effect of solvent and temperature on the lithium–iodine exchange of primary alkyl iodides: reaction of t-butyllithium with 1-iodooctane in heptane–ether mixtures William F. Bailey, Jason D. Brubaker, Kevin Jordan Journal of Organometallic Chemistry Deep Eutectic SolventChemical EngineeringPrimary Alkyl IodidesEngineeringOrganic Chemistry	2003	28
Identification of quinazoline based inhibitors of IRAK4 for the treatment of inflammation G. Smith, Michael D. Altman, Brian M. Andresen, Bioorganic & Medicinal Chemistry Letters InflammationMedicinal ChemistryAnti-inflammatoryPharmacologyImmunology	2017	25
Preparation of the Isomeric Azaindoline Family by Intramolecular Carbolithiation William F. Bailey, Paresh D. Salgaonkar, Jason D. Brubaker, Organic Letters Isomeric Azaindoline FamilyEngineeringBiochemistryWhereas Cyclization ProceedsOrganic Chemistry	2008	24

Page 1